• Maraviroc (UK-427857): Mechanistic Insights and Translationa

  2026-05-22

  Discover how Maraviroc, a selective CCR5 antagonist, advances both HIV-1 entry inhibition and neuroinflammation modulation. This article uniquely explores mechanistic details and translational strategies for Maraviroc in experimental and clinical research.

• Praeruptorin A Suppresses Poly (I:C)-Induced Inflammatory Pa

  2026-05-22

  The reference study demonstrates Praeruptorin A's ability to inhibit NF-κB activation and key inflammatory gene expression in poly (I:C)-stimulated RAW264.7 macrophages. These findings provide mechanistic insight into NF-κB-targeted anti-inflammatory strategies and inform the design of inflammation assay models relevant for viral and immune response research.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress

  2026-05-21

  This study demonstrates that mechanical stress-induced autophagy in human cells critically depends on cytoskeletal microfilaments, with microtubules playing a supportive role. These findings clarify the mechanotransduction pathway, informing future experimental approaches in cell signaling and cancer research.

• Epalrestat: Expanding Neuroprotection Beyond Diabetic Models

  2026-05-21

  Explore Epalrestat as an advanced aldose reductase inhibitor for oxidative stress research and neurodegenerative disease models. This article delivers a unique, in-depth analysis of KEAP1/Nrf2 pathway activation and practical assay considerations.

• AG-221 (Enasidenib): Systems Biology Insights for IDH2-Mutan

  2026-05-20

  Explore how AG-221 (Enasidenib) enables integrated, systems-level research on IDH2-mutant acute myeloid leukemia. This article offers original analysis on metabolic rewiring, resistance, and practical assay design—distinguishing it from existing protocol-centric guides.

• SM-102: Optimizing mRNA Delivery with Advanced Lipid Nanopar

  2026-05-20

  SM-102 stands out as a high-purity ionizable lipid engineered to enhance mRNA vaccine delivery through lipid nanoparticles. This guide walks researchers through real-world protocol improvements, data-driven comparative insights, and actionable troubleshooting to unlock reproducible, high-efficiency mRNA delivery for both vaccine and therapeutic applications.

• Spiroplasma eriocheiris Entry Mechanisms in Drosophila S2 Ce

  2026-05-19

  Wei et al. provide the first detailed characterization of how Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells, identifying clathrin-mediated endocytosis and macropinocytosis as key entry pathways. This work clarifies infection processes in invertebrate cell models and offers mechanistic insights relevant for infectious disease and cell biology research.

• BMX-IN-1: Redefining BMX Kinase Inhibition in Lysosomal Biol

  2026-05-19

  Explore how BMX-IN-1, a potent BMX kinase inhibitor, is driving new frontiers in lysosomal acidification research and host-pathogen interactions. This article delivers advanced insights and unique protocol considerations for cancer and infectious disease modeling.

• Wallichinine Reverses ABCB1-Mediated Multidrug Resistance in

  2026-05-18

  This study demonstrates that wallichinine, a natural compound from Piper wallichii, effectively reverses multidrug resistance (MDR) in cancer cells overexpressing the ABCB1 transporter. The findings provide mechanistic insight into how wallichinine restores chemosensitivity and offer a new direction for developing non-toxic MDR modulators from natural products.

• Metronidazole: Applied OAT3 Inhibition in Microbiota Researc

  2026-05-18

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) stands apart as both a nitroimidazole antibiotic and a precise OAT3 inhibitor, enabling advanced research in drug-drug interactions and microbiota-immune modulation. This article delivers actionable workflows, troubleshooting strategies, and data-driven insights for maximizing the impact of Metronidazole in bench-based studies.

• EDI3 Inhibition Reduces Viability in HER2+ Breast Cancer Res

  2026-05-17

  Keller et al. demonstrate that targeting EDI3, a key enzyme in choline metabolism, preferentially reduces viability and tumor growth in ER-HER2+ breast cancer cells resistant to HER2-targeted therapies. Their study uncovers EDI3 as a metabolic vulnerability and potential therapeutic target in this difficult-to-treat cancer subtype.

• Ferroptotic Tumor Cells Enhance Macrophage Antigen Presentat

  2026-05-16

  Sun et al. reveal that inducing ferroptosis in tumor cells reprograms tumor-associated macrophages to boost antigen presentation, thereby amplifying the efficacy of immune checkpoint blockade therapy. By delineating the mechanistic link between ferroptosis and adaptive anti-tumor immunity, this work provides a preclinical rationale for leveraging ferroptosis inducers to potentiate cancer immunotherapy.

• YTHDF2 Inhibition Enhances Memory via m6A mRNA Stabilization

  2026-05-15

  This study demonstrates that conditional knockout of YTHDF2 in the mouse forebrain leads to reduced degradation of m6A-modified mRNAs, resulting in increased synaptic transmission and enhanced hippocampus-dependent memory. The findings clarify the mechanistic role of YTHDF2-mediated mRNA decay in activity-dependent protein synthesis and cognitive function, with significant implications for neuroepigenetic research.

• Streamlining Macrolide Antibiotic Production via 3-O-Acyltra

  2026-05-15

  This study demonstrates the targeted genetic modification of Streptomyces spiramyceticus to produce a single-component macrolide antibiotic, 400-isovalerylspiramycin I, by in-frame partial deletion of the 3-O-acyltransferase gene. The approach addresses complexity in macrolide production, offering a path toward improved antibiotic manufacturing and specificity.

• Ionomycin Calcium Salt: Unleashing Calcium Ionophore Potenti

  2026-05-14

  Ionomycin calcium salt stands apart as a precise and potent calcium ionophore for dissecting intracellular Ca2+ dynamics, apoptosis induction, and tumor inhibition. This article delivers actionable protocols, troubleshooting advice, and context from the latest research—empowering scientists to harness Ionomycin in advanced cell signaling and cancer studies.

7616 records 12/508 page Previous Next First page 上5页 1112131415 下5页 Last page